
Paige is a pioneering AI-driven platform dedicated to transforming cancer diagnostics and precision oncology. By integrating advanced artificial intelligence with pathology workflows, Paige empowers pathologists and researchers to detect, grade, and quantify various cancers more accurately and efficiently. Its suite of AI applications supports the detection and classification of cancers across multiple tissue types, including prostate, breast, and gastrointestinal cancers. Additionally, Paige's technology facilitates the identification of over 1,600 biomarkers from H&E-stained slides, enhancing molecular profiling and personalized treatment strategies. By streamlining diagnostic processes and providing deeper insights into cancer pathology, Paige addresses critical challenges in oncology, ultimately improving patient outcomes and advancing the field of precision medicine.